CD4 T-Cell memory responses to viral infections of humans show pronounced immunodominance independent of duration or viral persistence

Journal of Virology

Volumn 87, Issue 5, 2013, Pages 2617-2627

  Jing, Lichen ^a   Schiffer, Joshua T ^a,b   Chong, Tiana M ^a   Bruckner, Joseph J ^a   Davies, D Huw ^c   Felgner, Phillip L ^c   Haas, Juergen ^d,e   Wald, Anna ^a,b   Verjans, G M G M ^f   Koellea, David M ^a,b,g  

^a UNIVERSITY OF WASHINGTON   (United States)

^b USA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF MUNICH   (Germany)

^e UNIVERSITY OF EDINBURGH   (United Kingdom)

^f ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

^g BENAROYA RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD137 ANTIGEN; CD4 ANTIGEN; DARYVAX; HERPES SIMPLEX VACCINE; HERPES SIMPLEX VIRUS 1 ANTIGEN; SMALLPOX VACCINE; UNCLASSIFIED DRUG; VIRUS ANTIGEN; VIRUS PROTEIN;

ADULT; ALLELE; ANTIBODY SPECIFICITY; ANTIGEN EXPRESSION; ARTICLE; CD4+ T LYMPHOCYTE; CELL SPECIFICITY; CELLULAR IMMUNITY; CONTROLLED STUDY; DISEASE DURATION; HERPES SIMPLEX; HUMAN; IMMUNODOMINANCE; IMMUNOREACTIVITY; LYMPHOCYTE COUNT; MATHEMATICAL ANALYSIS; MEMORY CELL; NONHUMAN; PERSISTENT VIRUS INFECTION; PRIORITY JOURNAL; UPREGULATION; VACCINIA VIRUS; VIRION;

ANTIGENS, CD137; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CELLS, CULTURED; HERPES SIMPLEX; HERPESVIRUS 1, HUMAN; HUMANS; IMMUNITY, CELLULAR; IMMUNOLOGIC MEMORY; INTERFERON-GAMMA; INTERLEUKIN-2; SMALLPOX VACCINE; TUMOR NECROSIS FACTOR-ALPHA; VACCINES, ATTENUATED; VACCINIA VIRUS;

EID: 84874735443     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.03047-12     Document Type: Article

References (48)

1. Sercarz EE, Lehmann PV, Ametani A, Benichou G, Miller A, Moudgil K. 1993. Dominance and crypticity of T cell antigenic determinants. Annu. Rev. Immunol. 11:729-766.
2. Oseroff C, Peters B, Pasquetto V, Moutaftsi M, Sidney J, Panchanathan V, Tscharke DC, Maillere B, Grey H, Sette A. 2008. Dissociation between epitope hierarchy and immunoprevalence in CD8 responses to vaccinia virus western reserve. J. Immunol. 180:7193-7202.
3. +T cell responses. J. Immunol. 178:6814-6820.
4. +T cells dominate the memory compartments of exposed subjects. J. Exp. Med. 202:673-685.
5. +) T cell frequency varies for different epitopes and predicts repertoire diversity and response magnitude. Immunity 27:203-213.
6. Jing L, Davies DH, Chong TM, Chun S, McClurkan CL, Huang J, Story BT, Molina DM, Hirst S, Felgner PL, Koelle DM. 2008. An extremely diverse CD4 response to vaccinia virus in humans is revealed by proteome-wide T-cell profiling. J. Virol. 82:7120-7134.
7. Mirano-Bascos D, Steede NK, Robinson JE, Landry SJ. 2010. Influence of disulfide-stabilized structure on the specificity of helper T-cell and antibody responses to HIV envelope glycoprotein gp120. J. Virol. 84:3303-3311.
8. + T-cell repertoire selection. Nat. Commun. 3:665.
9. Weaver JM, Chaves FA, Sant AJ. 2009. Abortive activation of CD4 T cell responses during competitive priming in vivo. Proc. Natl. Acad. Sci. U. S. A. 106:8647-8652.
10. Hammarlund E, Lewis MW, Hansen SG, Strelow LI, Nelson JA, Sexton GJ, Hanifin JM, Slifka MK. 2003. Duration of antiviral immunity after smallpox vaccination. Nat. Med. 9:1131-1137.
11. Kumar M, Hill JM, Clement C, Varnell ED, Thompson HW, Kaufman HE. 2009. A double-blind placebo-controlled study to evaluate valacyclovir alone and with aspirin for asymptomatic HSV-1 DNA shedding in human tears and saliva. Invest. Ophthalmol. Vis. Sci. 50:5601-5608.
12. Verjans GMGM, Hintzen RQ, van Dun JM, Poot A, Milikan JC, Laman JD, Langerak AW, Kinchington PR, Osterhaus ADME. 2007. Selective retention of herpes simplex virus specific T cells in latently infected human trigeminal ganglia. Proc. Natl. Acad. Sci. U. S. A. 104:3496-3501.
13. Jing L, Haas J, Chong TM, Bruckner JJ, Dann GC, Dong L, Marshak JO, McClurkan CL, Yamamoto TN, Bailer SM, Laing KJ, Wald A, Verjans GMGM, Koelle DM. 2012. Herpes simplex virus type 1 T-cells antigens in humans revealed by cross-presentation and genome-wide screening. J. Clin. Invest. 122:654-673.
14. Henderson DA, Borio LL, Lane JM. 2004. Smallpox and vaccinia, p 123-153. In Plotkin SA, Orenstein WA (ed), Vaccines, 4th ed. Saunders, Philadelphia, PA.
15. + T cell clones recovered from recurrent genital HSV-2 lesions. J. Virol. 68:2803-2810.
16. Jing L, Chong TM, Byrd B, McClurkan CL, Huang J, Story BT, Dunkley KM, Aldaz-Carroll L, Eisenberg RJ, Cohen GH, Kwok WW, Sette A, Koelle DM. 2007. Dominance and diversity in the primary human CD4 T cell response to replication-competent vaccinia virus. J. Immunol. 178: 6374-6386.
17. Jing L, McCaughey SM, Davies DH, Chong TM, Felgner PL, De Rosa SC, Wilson CB, Koelle DM. 2009. ORFeome approach to the clonal, HLA allele-specific CD4 T-cell response to a complex pathogen in humans. J. Immunol. Methods 347:36-45.
18. Lefkowitz EJ, Upton C, Changayil SS, Buck C, Traktman P, Buller RM. 2005. Poxvirus Bioinformatics Resource Center: a comprehensive Poxviridae informational and analytical resource. Nucleic Acids Res. 33(Database issue):D311-D316.
19. Zhu J, Hladik F, Woodward A, Klock A, Peng T, Johnston C, Remington M, Magaret A, Koelle DM, Wald A, Corey L. 2009. Persistence of HIV-1 receptor-positive cells after HSV-2 reactivation is a potential mechanism for increased HIV-1 acquisition. Nat. Med. 15:886-892.
20. Li F, Horton H, Gilbert PB, McElrath JM, Corey L, Self SG. 2007. HIV-1 CTL-based vaccine immunogen selection: antigen diversity and cellular response features. Curr. HIV Res. 5:97-107.
21. Jing L, Chong TM, McClurkan CL, Huang J, Story BT, Koelle DM. 2005. Diversity in the acute CD8 T cell response to vaccinia virus in humans. J. Immunol. 175:7550-7559.
22. Tait BD. 2011. The ever-expanding list of HLA alleles: changing HLA nomenclature and its relevance to clinical transplantation. Transplant. Rev. (Orlando) 25:1-8.
23. Moss NJ, Magaret A, Laing KJ, Kask AS, Wang M, Mark KE, Schiffer JT, Wald A, Koelle DM. 2012. Peripheral blood CD4 T-cell and plasmacytoid dendritic cell (pDC) reactivity to herpes simplex virus 2 and pDC number do not correlate with the clinical or virologic severity of recurrent genital herpes. J. Virol. 86:9952-9963.
24. Moretta A, Pantaleo G, Moretta L, Cerottini J-C, Mingari MC. 1983. Direct demonstration of the clonogenic potential of every human peripheral blood T cell. J. Exp. Med. 157:743-754.
25. Ferrer i Cancho R, Sole RV. 2003. Least effort and the origins of scaling in human language. Proc. Natl. Acad. Sci. U. S. A. 100:788-791.
26. Chung CS, Chen CH, Ho MY, Huang CY, Liao CL, Chang W. 2006. Vaccinia virus proteome: identification of proteins in vaccinia virus intracellular mature virion particles. J. Virol. 80:2127-2140.
27. Loret S, Guay G, Lippe R. 2008. Comprehensive characterization of extracellular herpes simplex virus type 1 virions. J. Virol. 82:8605-8618.
28. Corey L, Langenberg AGM, Ashley R, Sekulovich RE, Izu AE, Douglas JM, Handsfield H, Warren T, Marr L, Tyring S, DiCarlo R, Adimora AA, Leone P, Dekker CL, Burke RL, Leong WP, Straus SE. 1999. Two double-blind, placebo-controlled trials of a vaccine containing recombinant gD2 and gB2 antigens in MF59 adjuvant for the prevention of genital HSV-2 acquisition. JAMA 282:331-340.
29. Resch W, Hixson KK, Moore RJ, Lipton MS, Moss B. 2007. Protein composition of the vaccinia virus mature virion. Virology 358:233-247.
30. Kennedy R, Poland GA. 2007. T-Cell epitope discovery for variola and vaccinia viruses. Rev. Med. Virol. 17:93-113.
31. Sette A, Grey H, Oseroff C, Peters B, Moutaftsi M, Crotty S, Assarsson E, Greenbaum J, Kim Y, Kolla R, Tscharke D, Koelle D, Johnson RP, Blum J, Head S, Sidney J. 2009. Definition of epitopes and antigens recognized by vaccinia specific immune responses: their conservation in variola virus sequences, and use as a model system to study complex pathogens. Vaccine 27(Suppl 6):G21-G26.
32. + T cell help for antibody responses to a large viral pathogen: deterministic linkage of specificities. Immunity 28:847-858.
33. Yasukawa M, Zarling JM. 1985. Human cytotoxic T cell clones directed against herpes simplex virus-infected cells. III. Analysis of viral glycoproteins recognized by CTL clones by using recombinant herpes simplex viruses. J. Immunol. 134:2679-2682.
34. Kennedy RB, Poland GA. 2010. The identification of HLA class IIrestricted T cell epitopes to vaccinia virus membrane proteins. Virology 408:232-240.
35. Weaver JM, Sant AJ. 2009. Understanding the focused CD4 T cell response to antigen and pathogenic organisms. Immunol. Res. 45:123-143.
36. Handel A, Antia R. 2008. A simple mathematical model helps to explain the immunodominance of CD8 T cells in influenza A virus infections. J. Virol. 82:7768-7772.
37. + T cell clones in the naive polyclonal repertoire. Proc. Natl. Acad. Sci. U. S. A. 106: 11241-11245.
38. +) T cells correlates with immunodominance in the human memory repertoire. J. Immunol. 188:2537-2544.
39. + T cell survival controlled by clonal abundance. Science 312:114-116.
40. Surh CD, Sprent J. 2008. Homeostasis of naive and memory T cells. Immunity 29:848-862.
41. Varga SM, Selin LK, Welsh RM. 2001. Independent regulation of lymphocytic choriomeningitis virus-specific T cell memory pools: relative stability of CD4 memory under conditions of CD8 memory T cell loss. J. Immunol. 166:1554-1561.
42. + T cells contribute to lymphoproliferation in Epstein-Barr virusassociated infectious mononucleosis. J. Clin. Invest. 115:3602-3612.
43. + memory T cells: functional modules for tailored immunity. Eur. J. Immunol. 39: 2076-2082.
44. Curran MA, Kim M, Montalvo W, Al-Shamkhani A, Allison JP. 2011. Combination CTLA-4 blockade and 4-1BB activation enhances tumor rejection by increasing T-cell infiltration, proliferation, and cytokine production. PLoS One 6:e19499. doi:10.1371/journal.pone.0019499.
45. Snell LM, Lin GH, McPherson AJ, Moraes TJ, Watts TH. 2011. T-cell intrinsic effects of GITR and 4-1BB during viral infection and cancer immunotherapy. Immunol. Rev. 244:197-217.
46. +T cell repertoires specific for naturally processed antigens analyzed using libraries of amplified T cells. J. Exp. Med. 206:1525-1534.
47. Posavad CM, Remington M, Mueller DE, Zhao L, Magaret AS, Wald A, Corey L. 2010. Detailed characterization of T cell responses to herpes simplex virus-2 in immune seronegative persons. J. Immunol. 184:3250-3259.
48. Koelle DM, Johnson ML, Ekstrom AN, Byers P, Kwok WW. 1997. Preferential presentation of herpes simplex virus T-cell antigen by HLA DQA1*0501/DQB1*0201 in comparison to HLA DQA1*0201/DQB1*0201. Hum. Immunol. 53:195-205.